Deals - January 2022-0

Deals - January 2022


Deals - January 2022-0
Deals - January 2022-1

Crowe HAF / SeqOne Genomics

The company, which has already provided its genome sequencing data analysis platform to more than 15 institutions (university hospitals, private laboratories, etc.), is expanding internationally and continues to develop its solutions for a wider circle of professionals in order to improve and customise healthcare for cancer and rare diseases patients.

SeqOne Genomics closes a €20 million Series A round with Omnes, Mérieux Equity Partners and Software Club alongside its historical investors, with Elaia remaining as the main shareholder